Dual Inhibition of β-Adrenergic and Angiotensin II Receptors by a Single Antagonist
- 30 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (13) , 1611-1618
Abstract
Background— Although the renin–angiotensin and the β-adrenergic systems are interrelated, a direct interaction between β-adrenergic receptors (βARs) and angiotensin II type 1 receptors (AT 1 Rs) has not been identified. Methods and Results— Here, we provide evidence for a functional and physiological interaction between 2 G protein–coupled receptors: the βAR and the AT 1 R. Selective blockade of βARs in mouse cardiomyocytes inhibits angiotensin-induced contractility with an IC 50 that is similar to its inhibition of isoproterenol-mediated contractility. Furthermore, administration of the angiotensin receptor blocker valsartan to intact mice results in a significant reduction in the maximal response to catecholamine-induced elevation of heart rate. The mechanism for this transinhibitory effect of β-blockers and angiotensin receptor blockers is through receptor–G protein uncoupling; ie, β-blockers interfere with AT 1 R-G q coupling, and valsartan interferes with βAR-G s coupling. Finally, we demonstrate that AT 1 Rs and βARs form constitutive complexes that are not affected by ligand stimulation. As a result of these interactions, a single receptor antagonist effectively blocks downstream signaling and trafficking of both receptors simultaneously. Conclusions— We show that direct interactions between βARs and AT 1 Rs may have profound consequences on the overall response to drugs that antagonize these receptors.Keywords
This publication has 25 references indexed in Scilit:
- Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cellsBiochemical Journal, 2003
- Selective Inhibition of Heterotrimeric GsSignalingJournal of Biological Chemistry, 2002
- Seven-transmembrane-spanning receptors and heart functionNature, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Agonist-dependent Recruitment of Phosphoinositide 3-Kinase to the Membrane by β-Adrenergic Receptor Kinase 1Journal of Biological Chemistry, 2001
- Differential Affinities of Visual Arrestin, βArrestin1, and βArrestin2 for G Protein-coupled Receptors Delineate Two Major Classes of ReceptorsJournal of Biological Chemistry, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted MiceJournal of Biological Chemistry, 1998
- INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILUREThe Lancet, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987